These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17544750)

  • 1. Lowering homocysteine for stroke prevention.
    Carlsson CM
    Lancet; 2007 Jun; 369(9576):1841-1842. PubMed ID: 17544750
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.
    Wang X; Qin X; Demirtas H; Li J; Mao G; Huo Y; Sun N; Liu L; Xu X
    Lancet; 2007 Jun; 369(9576):1876-1882. PubMed ID: 17544768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid for stroke prevention.
    Sepe V; Adamo G; Giuliano MG; Libetta C; Dal Canton A
    Lancet; 2007 Aug; 370(9588):651; author reply 651. PubMed ID: 17720005
    [No Abstract]   [Full Text] [Related]  

  • 4. The vital amines: too much of a good thing?: comment on "Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality".
    Tice JA
    Arch Intern Med; 2010 Oct; 170(18):1631-3. PubMed ID: 20937920
    [No Abstract]   [Full Text] [Related]  

  • 5. [Homocysteine lowering with folic acid and B vitamins in vascular disease].
    Liakishev AA
    Kardiologiia; 2006; 46(5):70. PubMed ID: 16858361
    [No Abstract]   [Full Text] [Related]  

  • 6. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration
    Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
    Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
    Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
    Lonn E
    JAMA; 2008 May; 299(17):2086-7. PubMed ID: 18460669
    [No Abstract]   [Full Text] [Related]  

  • 9. Hopeful for a second HOPE-2 post hoc analysis.
    Righetti M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2428-9; author reply 2429-30. PubMed ID: 18403437
    [No Abstract]   [Full Text] [Related]  

  • 10. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
    JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
    Yang HT; Lee M; Hong KS; Ovbiagele B; Saver JL
    Eur J Intern Med; 2012 Dec; 23(8):745-54. PubMed ID: 22884409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials.
    Ebbing M; Bønaa KH; Arnesen E; Ueland PM; Nordrehaug JE; Rasmussen K; Njølstad I; Nilsen DW; Refsum H; Tverdal A; Vollset SE; Schirmer H; Bleie Ø; Steigen T; Midttun Ø; Fredriksen A; Pedersen ER; Nygård O
    J Intern Med; 2010 Oct; 268(4):367-82. PubMed ID: 20698927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
    Clarke R; Halsey J; Lewington S; Lonn E; Armitage J; Manson JE; Bønaa KH; Spence JD; Nygård O; Jamison R; Gaziano JM; Guarino P; Bennett D; Mir F; Peto R; Collins R;
    Arch Intern Med; 2010 Oct; 170(18):1622-31. PubMed ID: 20937919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nutritional medicine 2007].
    Hauner H
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1411-3. PubMed ID: 17570092
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Folic acid: an additional virtue?].
    Keller R
    Rev Med Suisse; 2015 May; 11(476):1212. PubMed ID: 26182643
    [No Abstract]   [Full Text] [Related]  

  • 17. C(1) metabolism and CVD outcomes in older adults.
    McNulty H; Strain JJ; Pentieva K; Ward M
    Proc Nutr Soc; 2012 May; 71(2):213-21. PubMed ID: 22152927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K
    Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine-lowering trials for prevention of heart disease and stroke.
    Clarke R
    Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.
    Spence JD; Stampfer MJ
    JAMA; 2011 Dec; 306(23):2610-1. PubMed ID: 22187282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.